260 related articles for article (PubMed ID: 15237988)
1. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
Lee JG; Sagui C; Roland C
J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
[TBL] [Abstract][Full Text] [Related]
2. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.
Lee JG; Sagui C; Roland C
J Phys Chem B; 2005 Nov; 109(43):20588-96. PubMed ID: 16853665
[TBL] [Abstract][Full Text] [Related]
3. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.
Rao J; Yan L; Lahiri J; Whitesides GM; Weis RM; Warren HS
Chem Biol; 1999 Jun; 6(6):353-9. PubMed ID: 10375541
[TBL] [Abstract][Full Text] [Related]
4. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.
McComas CC; Crowley BM; Boger DL
J Am Chem Soc; 2003 Aug; 125(31):9314-5. PubMed ID: 12889959
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.
Hong HJ; Hutchings MI; Neu JM; Wright GD; Paget MS; Buttner MJ
Mol Microbiol; 2004 May; 52(4):1107-21. PubMed ID: 15130128
[TBL] [Abstract][Full Text] [Related]
6. D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.
Jain RK; Trias J; Ellman JA
J Am Chem Soc; 2003 Jul; 125(29):8740-1. PubMed ID: 12862465
[TBL] [Abstract][Full Text] [Related]
7. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin.
Chiosis G; Boneca IG
Science; 2001 Aug; 293(5534):1484-7. PubMed ID: 11520986
[TBL] [Abstract][Full Text] [Related]
8. Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
Chang JD; Foster EE; Yang H; Kim SJ
Biochemistry; 2017 Jan; 56(4):612-622. PubMed ID: 28040891
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.
Nitanai Y; Kikuchi T; Kakoi K; Hanamaki S; Fujisawa I; Aoki K
J Mol Biol; 2009 Feb; 385(5):1422-32. PubMed ID: 18976660
[TBL] [Abstract][Full Text] [Related]
10. A liquid chromatography-tandem mass spectrometry assay for d-Ala-d-Lac: a key intermediate for vancomycin resistance in vancomycin-resistant enterococci.
Putty S; Vemula H; Bobba S; Gutheil WG
Anal Biochem; 2013 Nov; 442(2):166-71. PubMed ID: 23938774
[TBL] [Abstract][Full Text] [Related]
11. Experimental and theoretical studies of the structures and interactions of vancomycin antibiotics with cell wall analogues.
Yang Z; Vorpagel ER; Laskin J
J Am Chem Soc; 2008 Oct; 130(39):13013-22. PubMed ID: 18774809
[TBL] [Abstract][Full Text] [Related]
12. Gain of D-alanyl-D-lactate or D-lactyl-D-alanine synthetase activities in three active-site mutants of the Escherichia coli D-alanyl-D-alanine ligase B.
Park IS; Lin CH; Walsh CT
Biochemistry; 1996 Aug; 35(32):10464-71. PubMed ID: 8756703
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
[TBL] [Abstract][Full Text] [Related]
14. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
[TBL] [Abstract][Full Text] [Related]
15. In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall.
Kwun MJ; Novotna G; Hesketh AR; Hill L; Hong HJ
Antimicrob Agents Chemother; 2013 Sep; 57(9):4470-80. PubMed ID: 23836175
[TBL] [Abstract][Full Text] [Related]
16. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
Xie J; Pierce JG; James RC; Okano A; Boger DL
J Am Chem Soc; 2011 Sep; 133(35):13946-9. PubMed ID: 21823662
[TBL] [Abstract][Full Text] [Related]
17. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
Wu ZC; Boger DL
Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
[TBL] [Abstract][Full Text] [Related]
18. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation.
Park IS; Walsh CT
J Biol Chem; 1997 Apr; 272(14):9210-4. PubMed ID: 9083053
[TBL] [Abstract][Full Text] [Related]
19. Heterologous expression of glycopeptide resistance vanHAX gene clusters from soil bacteria in Enterococcus faecalis.
Hasman H; Aarestrup FM; Dalsgaard A; Guardabassi L
J Antimicrob Chemother; 2006 Apr; 57(4):648-53. PubMed ID: 16476725
[TBL] [Abstract][Full Text] [Related]
20. Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.
Xing B; Jiang T; Wu X; Liew R; Zhou J; Zhang D; Yeow EK
Chemistry; 2011 Dec; 17(50):14170-7. PubMed ID: 22083883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
